Sarepta Therapeutics, Inc. - Performance Stock Units Award to Chief Operating Officer

Ian Michael Estepan, Chief Operating Officer of Sarepta Therapeutics, Inc., was awarded 6,250 Performance Stock Units (PSUs) on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the company's achievement of prescribed milestones. These PSUs will vest on March 1, 2026, contingent upon Estepan's continued service with the company through that date. The transaction was reported on August 5, 2025. This award reflects the company's performance-based compensation strategy aimed at aligning executive incentives with corporate goals.